Despite its apparent simplicity, the blocking step can significantly impact the quality of a western blot, with the choice of blocking agent, concentration, and incubation conditions playing a vital role in the outcome. This article explores various western blot blocking methods, compares commonly used blocking agents, and provides best practices to optimize blocking conditions.

How blocking works: Mechanism and importance

Types of blocking agents

Blocking agents for western blotting can be categorized into protein-based and non-protein blockers, each serving to reduce background noise and improve the clarity of results. The choice between these blockers depends on the specific needs of the experiment, including the target proteins and detection methods used.

Protein-based blockers

Non-fat dry milk (NFDM) solution is commonly used as a protein-based blocker to saturate unoccupied protein-binding sites on membranes during western blotting.

BSA is a widely used protein-based blocker for saturating excess protein-binding sites on membranes in western blotting.

Normal serum, derived from non-immunized animals, is commonly used as a blocking agent in immunoassays to reduce background by saturating non-specific binding sites, particularly Fc receptors and conserved sequences, ensuring clearer experimental results.

Non-protein blockers

Polyvinylpyrrolidone (PVP) is a synthetic polymer used as a non-protein blocking agent in immunochemical studies, effectively reducing non-specific binding by creating a hydrophilic barrier on membranes, which minimizes background signal without interacting with proteins in the assay.

Tween 20 is commonly used in western blotting as a detergent rather than a primary blocker, helping to reduce background and non-specific binding by preventing excessive adherence of antibodies to the membrane. However, it can cause autofluorescence if not properly washed out before imaging, especially when dried on membranes.

Some commercial western blot blocking buffers include:

• Abcam’s 10X blocking buffer (ab126587), a protein-based, serum-free solution (pH 7.5) designed to block non-specific antibody binding in immunocytochemistry (ICC), enzyme-linked immunosorbent assay (ELISA), and western blotting.
• Abcam’s immunoassay blocking buffer (ab171534) preserves protein conformation and activity in immunoassays, providing superior blocking and stabilization.
• Abcam’s protein block (ab64226) is a ready-to-use, serum-free blocking buffer for reducing non-specific antibody binding in immunohistochemistry (IHC), ELISA, and western blotting.

Comparison of blocking buffers

Tris-buffered saline (TBS) consists of Tris base and NaCl, and it is often used as a wash or diluent buffer. Its primary function is to maintain the pH and ionic strength, providing a stable environment for protein interactions. In western blotting, TBS can be used with or without the addition of Tween 20 (TBST) to reduce non-specific antibody binding.

Blocking buffers (3-5% BSA or milk) are essential in western blotting to prevent the non-specific binding of antibodies to the membrane. Typically, 3-5% BSA or non-fat dry milk in TBS or TBST is used. BSA is preferred when working with phosphoproteins, as it lacks phosphoproteins found in milk, which may interfere with the assay. Non-fat dry milk is commonly used for general blocking purposes due to its low cost and effectiveness in reducing background noise during detection.

TBST (TBS + Tween 20) is TBS with the addition of the detergent Tween 20, which is used to reduce non-specific binding and wash away unbound antibodies in immunoassays. Tween 20 improves the overall washing efficiency by reducing surface tension, allowing it to disrupt weak interactions between antibodies and the membrane. This is especially useful in western blotting, where background noise can be an issue.

10X phosphate-buffered saline (PBS) is a concentrated buffer used in ELISA development and immuno-labeling procedures, such as immunohistochemistry paraffin (IHC-P). The powder form is dissolved in distilled deionized water to create a 1 L stock solution, which is then diluted 10-fold to make a 1X working solution for washing during experiments.

Choosing the right buffer

When choosing between TBS and PBS for western blotting, the decision depends on the specific proteins and antibodies involved. TBS is recommended for detecting phosphorylated proteins and when using alkaline phosphatase (AP)-conjugated antibodies as PBS can interfere with these. For most other applications, TBS and PBS are generally interchangeable, though it is worth experimenting to optimize results.

Fluorescent western blotting

To minimize autofluorescence in fluorescent western blotting, it is advisable to avoid phosphate-based buffers, such as PBS. Phosphate can interfere with antibody interactions and increase background signals, particularly when detecting phosphorylated proteins. Instead, TBS is recommended for improved results with fluorescent detection.

Blocking procedure: Best practices

Properly executing the blocking procedure enhances clarity, precision, and overall accuracy, which is particularly important when handling complex samples or conducting a western blot for larger proteins.

Blocking steps in western blot

• Preparation of blocking buffer: The blocking buffer is prepared by dissolving either 3-5% non-fat dry milk, BSA, or fish gelatin in TBS or PBS, typically with 0.1% Tween-20. The buffer should be mixed thoroughly and filtered to remove any particulate matter, which can cause spotting on the membrane during detection.
• Incubation time and temperature: The membrane should be incubated in the blocking buffer for 30 minutes to 1 hour at room temperature with gentle rocking. For more sensitive proteins, overnight incubation at 4°C may be used to enhance blocking efficiency.
• Washing membranes after blocking: After blocking, the membrane is washed three times with TBS or PBS containing 0.1% Tween-20 for 5-10 minutes each. This step ensures the removal of excess blocking buffer and prepares the membrane for antibody incubation, reducing background noise during detection.

Factors affecting blocking efficiency

• Membrane type (Nitrocellulose vs. PVDF): The choice between nitrocellulose and PVDF membranes impacts blocking efficiency. Nitrocellulose membranes are generally easier to block but may not be ideal for high molecular weight proteins due to limited binding capacity. PVDF membranes, on the other hand, have higher protein binding capacity and work well in applications involving a western blot for high molecular weights, though they may require more rigorous blocking to avoid non-specific binding.
• Target protein characteristics: The protein’s size, charge, and structure influence blocking effectiveness. For example, larger proteins or those with a complex tertiary structure may interact differently with the membrane and blocking agents, so optimizing the blocking conditions is essential for accurate detection.
• Antibody specificity: Certain antibodies have a higher tendency for non-specific binding, which can be exacerbated if blocking is insufficient. In such cases, additional or prolonged blocking steps may help reduce background noise, enabling the antibody to interact more specifically with the target protein.

Optimizing blocking conditions

• Adjusting blocker concentration: Optimizing the concentration of the blocking agent, such as non-fat dry milk (NFDM) or BSA, is crucial to prevent non-specific binding without reducing signal intensity. It is recommended to start with a 5% solution and make adjustments based on the background signal or protein binding efficiency.
• Modifying incubation time and temperature: Varying the blocking time (typically 1 hour at room temperature or overnight at 4°C) and temperature can influence blocking efficiency. These parameters can be based on antibody performance and background interference.
• Testing different blocking agents: If non-specific binding persists, testing alternative blocking agents such as BSA, casein, or commercial blocking buffers may improve results by reducing background while maintaining protein signal detection. Testing different blocking agents in sample preparation for western blot can help identify the best fit for reducing non-specific signals and enhancing target protein clarity.

Common issues and troubleshooting

Troubleshooting common issues in western blotting, such as high background signals, poor protein detection, or non-specific bands, is essential for achieving reliable results. By identifying and addressing these challenges, researchers can enhance the accuracy and clarity of their western blot experiments.

High background signal

A common issue during the blocking step in western blotting is high background, often caused by incomplete blocking or antibodies binding to proteins in the blocking buffer. Solutions include increasing the blocking buffer concentration, extending the blocking time, using a higher temperature for blocking, or switching to a different blocking agent.

Poor signal or faint bands

Weak or absent signals can result from blocking buffer interference with protein-antibody interactions. To resolve this, reduce the concentration of the blocking buffer, eliminate detergents, or switch to a different blocking agent.

Non-specific bands

Multiple non-specific bands may result from insufficient blocking. To address this, increase the blocking buffer concentration, extend the blocking time, block at a higher temperature, or add Tween-20 to enhance blocking efficiency.

Special considerations for fluorescent western blotting

When performing fluorescent western blotting, it is important to use high-quality, filtered buffers to prevent contamination and avoid fluorescent artifacts. Limiting the use of detergents is also crucial, as they can auto-fluoresce and increase non-specific background, interfering with signal detection. By ensuring clean western blot reagents and reducing detergent use, the clarity and accuracy of fluorescent detection can be significantly improved.

Alternative blocking strategies

Peptides can serve as effective blocking agents in western blotting by competing with the primary antibody for binding to the target protein, thereby validating antibody specificity. When the antibody is preincubated with a blocking peptide, it should no longer bind to the target, resulting in the disappearance of the specific band. This technique helps ensure that the observed signal is from the intended protein and not due to non-specific binding.

Antibodies can be used as blocking agents in immunoassays, particularly in cases where non-specific binding of secondary antibodies or Fc receptor-mediated interactions need to be prevented. For example, Fc fragment-specific antibodies can block Fc receptor sites to minimize non-specific binding in tissues with high Fc receptor expression. This is often useful in applications like IHC or ICC. Additionally, using pre-adsorbed antibodies ensures minimal cross-reactivity with endogenous immunoglobulins, further improving assay specificity.

Immunoblotting vs. western blotting

Western blotting and immunoblotting are terms often used interchangeably, but there's a subtle difference in emphasis. Western blotting as a technique involves protein extraction, gel electrophoresis, membrane transfer, and visualization. Immunoblotting emphasizes the detection phase in western blotting, where specific antibodies are used to target and identify proteins of interest on the membrane.

Western blotting is the overarching technique, and immunoblotting refers to the antibody-based detection within it. However, in most contexts, they are used interchangeably because antibody detection is typically a key feature of western blots.

FAQs